相关实验视频
Updated: Jan 9, 2026

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.9K
脂质过氧化和慢性炎症在血栓后综合征发展中的作用
1Department of Vascular Surgery, Zhejiang Hospital, Hangzhou, Zhejiang, China.
Archives of physiology and biochemistry
|December 5, 2025
概括
血栓后综合征 (PTS) 与脂质过氧化和炎症有关. 测量MDA,IL-6和TNF-α等生物标志物可以帮助预测,预防和管理PTS,改善患者的治疗结果.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 血栓后综合征 (PTS) 是深静脉血栓症 (DVT) 后的慢性并发症,其特征是疼痛,胀和皮肤.
- PTS的进展与内皮损伤,静脉压力增加和纤维化有关,严重影响患者的生活质量.
- 氧化应激和慢性炎症被认为是PTS病变的关键驱动因素.
研究的目的:
- 研究脂质过氧化和慢性炎症在PTS的发展和进展中的作用.
- 提出并验证一种基于生物标志物的ELISA方法,用于检测DVT后患者的早期生物化学变化.
- 评估氧化和炎症标志物的潜力,作为PTS的诊断和治疗点.
主要方法:
- 使用酶相关免疫吸收试验 (ELISA) 来量化脂质过氧化产品的血水平,特别是甲 (MDA).
- 测量了促炎性细胞因子的度,包括互乐金-6 (IL-6) 和瘤坏死因子-α (TNF-α).
- 与临床症状和结局相关的生物标志物水平,使用国家卫生服务 (NHS) 的观察数据.
主要成果:
- 高水平的MDA,IL-6和TNF-α与PTS的存在和严重程度密切相关.
- 初步数据显示,受影响患者的平均MDA水平为14.3 ± 4.1nmol/mL,IL-6为2.3 ± 1.1pg/mL,TNF-α为1.5 ± 0.7pg/mL.
- 拟议的生物标志物查显示了提高PTS预测 (98.7%),预防 (97.3%) 和管理 (99.4%) 的高潜力.
结论:
- 脂质过氧化和慢性炎症是PTS病变发生的重要因素.
- 生物标志物如MDA,IL-6和TNF-α对PTS的早期检测和风险分层显示出希望.
- 针对这些氧化和炎症途径可能会导致改善预防和管理PTS的治疗策略.
相关概念视频
Coronary Artery Disease II: Pathophysiology
342
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Peripheral Artery Disease I: Introduction
290
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
290
Venous Thrombosis I: Introduction
310
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
310
Atherosclerosis I: Introduction
818
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
818
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Inflammation
61.5K
Overview
61.5K

